Swiss pharma giant Roche posted positive results on Thursday of its phase-1 clinical trail for its experimental weight loss drug CT-388.
Swiss pharma giant Roche posted positive results on Thursday of its phase-1 clinical trail for its experimental weight loss drug CT-388.